Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012;7(2):e31591.
doi: 10.1371/journal.pone.0031591. Epub 2012 Feb 24.

Adherence to antiretroviral treatment and correlation with risk of hospitalization among commercially insured HIV patients in the United States

Paul E Sax  1 , Juliana L Meyers, Michael Mugavero, Keith L Davis
Affiliations

Adherence to antiretroviral treatment and correlation with risk of hospitalization among commercially insured HIV patients in the United States

Paul E Sax et al. PLoS One. 2012.

Abstract

Purpose: A lower daily pill burden may improve adherence to antiretroviral treatment (ART) and clinical outcomes in patients with human immunodeficiency virus (HIV). This study assessed differences in adherence using the number of pills taken per day, and evaluated how adherence correlated with hospitalization.

Methodology: Commercially insured patients in the LifeLink database with an HIV diagnosis (International Classification of Diseases, 9th Revision, Clinical Modification code 042.xx) between 6/1/2006 and 12/31/2008 and receipt of a complete ART regimen were selected for inclusion. Patients were grouped according to their daily pill count and remained on ART for at least 60 days. Outcomes included adherence and rates of hospitalization. Adherence was measured as the proportion of days between the start and end of the regimen in which the patient maintained supply of all initiated ART components. Logistic regressions assessed the relationship between pills per day, adherence, and hospitalization, controlling for demographics, comorbidities, and ART-naïve (vs. experienced) status.

Results: 7,073 patients met the study inclusion criteria, and 33.4%, 5.8%, and 60.8% received an ART regimen comprising one, two, or three or more pills per day, respectively. Regression analysis showed patients receiving a single pill per day were significantly more likely to reach a 95% adherence threshold versus patients receiving three or more pills per day (odds ratio [OR] = 1.59; P<0.001). Regardless of the number of pills received per day, patients were over 40% less likely to have a hospitalization if they were adherent to therapy (OR = 0.57; P<0.001). Patients receiving a single pill per day were 24% less likely to have a hospitalization versus patients receiving three or more pills per day (OR = 0.76; P = 0.003).

Conclusions: ART consisting of a single pill per day was associated with significantly better adherence and lower risk of hospitalization in patients with HIV compared to patients receiving three or more pills per day.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: This study was funded by Gilead Sciences.

Figures

Figure 1
Figure 1. Sample Selection Flow Chart.
Figure 2
Figure 2. Frequency of Hospitalizations, by Cohorta.
Figure 3
Figure 3. Adjusted Rate of Hospitalization, by Cohort.
See this image and copyright information in PMC

References

    1. Fielden SJ, Rusch ML, Yip B, Wood E, Shannon K, et al. Nonadherence increases the risk of hospitalization among HIV-infected antiretroviral naïve patients started on HAART. J Int Assoc Physicians AIDS Care. 2008;7:238–244. - PubMed
    1. Kitahata MM, Reed SD, Dillingham PW, Van Rompaey SE, Young AA, et al. Pharmacy-based assessment of adherence to HAART predicts virological and immunologic treatment response and clinical progression to AIDS and death. Int J STD AIDS. 2004;15:803–810. - PubMed
    1. Hogg RS, Yip B, Harrigan PR, O'Shaughnessy MV, et al. Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4+ cell count is 0.200 to 0.350×109 cells/L. Ann Intern Med. 2003;139:810–816. - PubMed
    1. Bangsberg DR, Perry S, Charlebois ED, Clark RA, Roberston M, et al. Nonadherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS. 2001;15:1181–1183. - PubMed
    1. Paterson DL, Swindells S, Mohr J, Brester M, Vergis EN, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133:21–30. - PubMed

Publication types

Substances